Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

A Facile and Efficient Method for Synthesis of Macrocyclic Lipoglycopeptide

Synthesis and Antibacterial Activities of N-Glycosylated Derivatives of Tyrocidine A, A Macrocyclic Peptide Antibiotic

Synthesis Of Gramicidin S And Its Analogues Via An On-Resin Macrolactamization Assisted By A Predisposed Conformation Of The Linear Precursors

Macrocyclic Peptide Construction Through C-H Activation Strategy.

Solution- and Solid-Phase Macrocyclization of Peptides by the Ugi-Smiles Multicomponent Reaction: Synthesis of N-Aryl-Bridged Cyclic Lipopeptides

Total Liquid-phase Sythesis, Head-to-tail Cyclization and Synergistic Self-cleavage of Peptide on Small-molecular Supports

A novel method for the synthesis of macrocyclic peptides using arylsulfonyloxyacetic acids as N -terminus functional groups

Synthesis of tyrocidine A and its analogues by spontaneous cyclization in aqueous solution.

Recent Developments in Peptide Macrocyclization

Head-to-tail Cyclization for the Synthesis of Naturally Occurring Cyclic Peptides on Organophosphorus Small-Molecular Supports

Biocompatible Synthesis of Macrocyclic Thiazol(in)e Peptides

Construction of Complex Macromulticyclic Peptides via Stitching with Formaldehyde and Guanidine

Macrocyclization of Bioactive Peptides with Internal Thiazole Motifs Via Palladium-Catalyzed C–H Olefination

One-Pot Cyclization to Large Peptidomimetic Macrocycles by In Situ-Generated β-Turn-Enforced Folding

Peptide Macrocyclization via Cu-catalyzed 1,3-Dipolar Cycloaddition of Azomethine Ylides

Biosynthetic Strategies for Macrocyclic Peptides

Peptide Macrocycles Developed from Precisely Regulated Multiple Cyclization of Unprotected Peptides

Peptide Macrocyclization Through Palladium-Catalyzed Late-Stage C-H Activation.

Solid-Phase Synthesis and Self-Assembly Formation of Tyrocidines

Advancing multicomponent strategies to macrobicyclic peptides

Synthesis and Functionalization of Azetidine‐Containing Small Macrocyclic Peptides